跳至主要内容
临床试验/CTRI/2014/08/004859
CTRI/2014/08/004859进行中(未招募)未知

A Prospective Study to Characterize the Management and Outcome of Clostridium difficile Infection in Asian Pacific Countries.

Otsuka Pharmaceutical Co Ltd0 个研究点目标入组 627 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
627

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Patients must meet the following criteria in order to be enrolled in the study:
  • Patients with a confirmed diagnosis of CDI, as documented by diarrheal symptoms and positive stool test result for CDT or toxigenic C. difficile, or colonoscopic findings of PMC
  • Patients and/or legal guardian willing to provide informed consent and/or informed assent or data release, according to local regulations.

排除标准

  • Patients who meet the following criteria will not be enrolled in the study:
  • Patients with diarrheal symptoms caused by bacteria other than C. difficile, such as Salmonella, Campylobacter, Vibrio, Shigella, and Escherichia coli.

研究者

相似试验